Cuprina Holdings (Cayman) LTD (NASDAQ:CUPR) Short Interest Update

Cuprina Holdings (Cayman) LTD (NASDAQ:CUPR – Get Free Report) was the recipient of a large decline in short interest in May. As of May 29th, there was short interest totaling 85,189 shares, a decline of 69.4% from the May 14th total of 278,140 shares. Approximately 3.3% of the company’s shares are short sold. Based on an average daily volume of 417,303 shares, the short-interest ratio is presently 0.2 days.

Analyst Ratings Changes

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Cuprina Holdings (Cayman) in a research note on Friday, April 24th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company presently has an average rating of “Sell”.

Get Cuprina Holdings (Cayman) alerts:

View Our Latest Stock Analysis on Cuprina Holdings (Cayman)

Cuprina Holdings (Cayman) Trading Up 2.0%

NASDAQ:CUPR traded up $0.05 during mid-day trading on Thursday, hitting $2.31. 150,698 shares of the company’s stock were exchanged, compared to its average volume of 206,168. Cuprina Holdings has a one year low of $1.76 and a one year high of $76.00. The company has a debt-to-equity ratio of 0.07, a current ratio of 2.35 and a quick ratio of 2.35. The company has a fifty day moving average price of $2.51.

Cuprina Holdings (Cayman) (NASDAQ:CUPR – Get Free Report) last posted its quarterly earnings data on Monday, April 27th. The company reported ($0.40) EPS for the quarter. The company had revenue of $0.01 million for the quarter.

About Cuprina Holdings (Cayman)

(Get Free Report)

We are a Singapore-based biomedical and biotechnology company that is dedicated to the development and commercialization of innovative products for the management of chronic wounds, as well as operating in the health and beauty sectors. Our expertise in biomedical research allows us to identify and utilize materials derived from natural sources to develop wound care products in the form of medical devices which meet international standards. We believe we will be able to build upon and leverage such expertise to develop innovative cosmeceutical products in the future.

Recommended Stories

• Five stocks we like better than Cuprina Holdings (Cayman)
• The World Cup Is Coming—These 3 Stocks Could Cash In
• Spotify’s “North Star” Outlook Was Music to Investors Ears
• Patent Cliff Predators: GSK Acquires Nuvalent For $10.6 Billion
• Cracker Barrel Surges 23% as Earnings Beat Signals Turnaround Progress

Receive News & Ratings for Cuprina Holdings (Cayman) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cuprina Holdings (Cayman) and related companies with MarketBeat.com's FREE daily email newsletter.